How many people with ADHD get treatment

A quarter of children and fewer than a sixth of adults with ADHD received pharmacological treatment, with regional rates varying by up to twelve-fold.

The short version

Prescribing studies show only 25% of children and 15% of adults with ADHD received pharmacological treatment.
Regional rates across the UK vary up to 12-fold.
The Taskforce concludes that waiting times for NHS ADHD services have escalated and are unacceptably long.
Treatment rate is not the same as need, and neither figure is a recommendation about treatment.

Waiting lists are the visible part of this system. Treatment rates describe what happens after the list, and the Taskforce's figures on them are arguably the more striking pair of numbers.

The figures

The Taskforce reports that the latest data from prescribing studies show that only 25% of children and 15% of adults with ADHD received pharmacological treatment, with regional rates across the UK varying up to 12-fold.

The twelve-fold variation is the part worth sitting with. It describes a difference between places, not between people, which means where someone lives is doing a great deal of work in determining what happens to them.

How to read them carefully

These are treatment rates among people with ADHD, so they describe coverage rather than need, and they say nothing about whether medication is the right treatment for any individual. That is a clinical question for a prescriber, and nothing on this page bears on it.

They also sit alongside the recognition gap: the Taskforce reports administrative prevalence in English records of 2.55% in boys and 0.67% in girls, and 0.74% in men and 0.20% in women, against the population prevalence it states for each group, 5% in children and 2 to 3% in adults. On the Taskforce's own reading, under-recognition of ADHD remains a problem in England. Low recorded prevalence and low treatment rates compound each other.

What it implies for the pathway

If regional variation in treatment is that wide, then choosing a provider that prescribes and reviews is not a detail. NHS South West London ICB warns that not all Right to Choose providers can start medicine or prescribe it and that some only offer an assessment or diagnosis, which is the same variation showing up as a choice in front of you.

It also gives weight to the Taskforce's own summary finding, listed among its numbered conclusions: waiting times for NHS ADHD services have escalated and are unacceptably long.

Questions people ask about this

What proportion of people with ADHD receive medication?

The independent ADHD Taskforce reports that the latest data from prescribing studies show only 25% of children and 15% of adults with ADHD received pharmacological treatment, with regional rates across the UK varying up to 12-fold. That describes coverage across populations and says nothing about whether medication is right for any individual, which is a question for a prescriber.

Why does ADHD treatment vary so much by region?

The Taskforce records the variation, up to 12-fold across the UK, without this site adding an explanation it has no source for. What is visible on the pathway itself is that providers differ in whether they prescribe at all: NHS South West London ICB warns that some Right to Choose providers only offer an assessment or diagnosis.